Atossa Therapeutics
ATOS
$1.70
Share price
-1.16%
Change (1 day)
142.86%
Change (1 year)
Categories
Market capitalization of Atossa Therapeutics (ATOS)
Market cap: $0.21 Billion
As of May 2024 Atossa Therapeutics has a market cap of $0.21 Billion. This makes Atossa Therapeutics the world's 6896th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Atossa Therapeutics from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.21 B | 93.18% |
| 2023 | $0.11 B | 64.77% |
| 2022 | $66.92 M | -66.97% |
| 2021 | $0.20 B | 348.51% |
| 2020 | $45.17 M | 215.1% |
| 2019 | $14.33 M | 140.39% |
| 2018 | $5.96 M | -28.75% |
| 2017 | $8.36 M | 56.7% |
| 2016 | $5.34 M | -48.89% |
| 2015 | $10.45 M | -70.25% |
| 2014 | $35.12 M | -18.48% |
| 2013 | $43.09 M | -14.47% |
| 2012 | $50.38 M |
End of Day market cap according to different sources
On May 7th, 2024 the market cap of Atossa Therapeutics was reported to be:
$0.21 Billion
$0.21 Billion
$0.21 Billion
$0.21 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $357.92 B | 167,924.99% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $15.21 B | 7,041.66% | 🇺🇸 USA |
 LabCorp LH | $16.98 B | 7,873.62% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $2.82 B | 1,225.68% | 🇺🇸 USA |
 NeoGenomics
NEO | $1.98 B | 833.48% | 🇺🇸 USA |
 Enzo Biochem ENZ | $55.83 M | -73.79% | 🇺🇸 USA |